Growing Use Of Cell-Based Assays Reported In Genetic Engineering & Biotechnology News

Biotech and pharma companies are increasingly relying on cell-based assays in early drug discovery work, reports Genetic Engineering & Biotechnology News (GEN). The technique can provide a quick and lower cost means of testing drug candidates for toxic effects, according to an article in GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2437).

More: continued here

Filed under: Medical Devices on April 17th, 2008